Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461420 · ClinicalTrials.gov registry record
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
A clinical trial of Autism Spectrum Disorder and Intellectual Disability, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 205
- Enrollment target
- 5
- Study locations
NCT02461420: Active study of Autism Spectrum Disorder and Intellectual Disability, sponsored by Boston Children's Hospital.
NCT02461420 is a study of Autism Spectrum Disorder and Intellectual Disability that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 205 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (53% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02461420, a study of Autism Spectrum Disorder and Intellectual Disability, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 205 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, including diffusion tensor imaging and identify genetic factors which contribute to diverse phenotypes in patients with PMS.
Primary Outcome
Using Mullen Scales for Early Learning or Stanford Binet-5 to measure global cognitive ability
Conditions Studied
Study Locations (5)
California
- Stanford University - Stanford
Illinois
- Rush University Medical Center - Chicago
Maryland
- National Institutes of Health - Bethesda
Massachusetts
- Boston Children's Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2015-05 |
| Est. Completion | 2026-12 |
What the registry record for NCT02461420 still lists
NCT02461420 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (53% higher).
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT02461420 lists 5 locations in 5 states (California, Illinois, Maryland).
Frequently Asked Questions
What is clinical trial NCT02461420 about?
NCT02461420 is a clinical study titled "Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome". The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, ...
What is the current status of trial NCT02461420?
This trial is currently active not recruiting. The enrollment target is 205 participants. The study started on 2015-05. Estimated completion is 2026-12.
What conditions does trial NCT02461420 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Intellectual Disability, Phelan-McDermid Syndrome.
Who is sponsoring clinical trial NCT02461420?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02461420 being conducted?
This trial has 5 study locations across California, Illinois, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02461420's enrollment target sits among peer trials
205 37th of 224 higher than 188 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia